Arbaclofen placarbil (CHEM101842)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-05 12:44:04 UTC | ||||||||
| Update Date | 2026-08-20 03:59:20 UTC | ||||||||
| Accession Number | CHEM101842 | ||||||||
| Identification | |||||||||
| Common Name | Arbaclofen placarbil | ||||||||
| Class | Small Molecule | ||||||||
| Description | Arbaclofen placarbil is an organic compound with the formula C19H26ClNO6 and an average molecular weight of 399.87 g/mol. Arbaclofen placarbil belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. In terms of its pharmacological activity, the compound acts as an agonist for three recorded protein targets. These targets include the Gamma-aminobutyric acid type B receptor subunit 1 (GABBR1), the Gamma-aminobutyric acid type B receptor subunit 2 (GABBR2), and the Gamma-aminobutyric acid receptor subunit gamma-3 (GABRG3). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C19H26ClNO6 | ||||||||
| Average Molecular Mass | 399.870 g/mol | ||||||||
| Monoisotopic Mass | 399.145 g/mol | ||||||||
| CAS Registry Number | 847353-30-4 | ||||||||
| IUPAC Name | (3R)-3-(4-chlorophenyl)-4-({[(1S)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy]carbonyl}amino)butanoic acid | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C | ||||||||
| InChI Identifier | InChI=1S/C19H26ClNO6/c1-11(2)17(24)26-18(12(3)4)27-19(25)21-10-14(9-16(22)23)13-5-7-15(20)8-6-13/h5-8,11-12,14,18H,9-10H2,1-4H3,(H,21,25)(H,22,23)/t14-,18-/m0/s1 | ||||||||
| InChI Key | JXTAALBWJQJLGN-KSSFIOAISA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
